Home › Pneumonia › California › Los Angeles
Pneumonia clinical trials in Los Angeles, CA
4 studies for Pneumonia are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RecruitingPhase 3
- Downtown L.A. Research Center, Inc., Los Angeles
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
RecruitingObservational study
- Kaiser Permanente West Los Angeles Medical Center, Los Angeles
Immune Defense Protein Impact On Respiratory Immune Outcomes
RecruitingHealthy volunteers welcome
- People Science, Inc., Los Angeles
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
RecruitingPhase 2
- aTyr Investigative Site, Los Angeles
About Pneumonia
Pneumonia is an infection in one or both of the lungs. Symptoms of pneumonia vary to mild to severe. Read about the signs of pneumonia.
More about Pneumonia on MedlinePlus
Pneumonia trials in other cities
- Houston, TX8 studies
- Chicago, IL6 studies
- Salt Lake City, UT6 studies
- Boston, MA5 studies
- Durham, NC5 studies
- Washington, DC5 studies
- Cincinnati, OH4 studies
- Dallas, TX4 studies
- Hialeah, FL4 studies
- Philadelphia, PA4 studies
- St. Louis, MO4 studies
- Atlanta, GA4 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.